The microRNA processor DROSHA is a candidate gene for a severe progressive neurological disorder

Scott Barish1,2, Mumine Senturk1,2,3,4, Kelly Schoch5

  • 1Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX 77030, USA.

Insights

Damaging variants in the DROSHA gene, crucial for microRNA (miRNA) biogenesis, are linked to severe neurodevelopmental disorders. Functional studies in model organisms confirm these variants disrupt miRNA production and cause disease phenotypes.

Area of Science:

  • Genetics
  • Molecular Biology
  • Developmental Biology

Background:

  • DROSHA is a key ribonuclease in the Microprocessor complex, essential for the initial step of microRNA (miRNA) biogenesis.
  • Mendelian diseases associated with DROSHA have not been previously identified.

Purpose of the Study:

  • To investigate the potential role of DROSHA variants in severe neurodevelopmental disorders.
  • To functionally characterize identified DROSHA variants using model organisms.

Main Methods:

  • Clinical evaluation of two individuals with profound intellectual disability, epilepsy, microcephaly, and dysmorphic features.
  • Genetic analysis to identify de novo heterozygous variants in DROSHA.
  • Functional studies in Drosophila melanogaster (fruit flies) and Caenorhabditis elegans (worms) to assess the impact of DROSHA variants.

Main Results:

  • Two individuals presented with severe phenotypes and carried damaging de novo heterozygous variants in DROSHA.
  • Functional assays in flies indicated that one variant (p.Asp1219Gly) acts as a strong loss-of-function allele, while another (p.Arg1342Trp) is less detrimental.
  • Worm studies mimicking the p.Asp1219Gly variant resulted in loss of miRNA expression and heterochronicity, confirming a loss-of-miRNA phenotype.

Conclusions:

  • The identified de novo heterozygous variants in DROSHA are damaging and likely cause severe nervous system phenotypes.
  • This study establishes a link between DROSHA dysfunction and Mendelian neurodevelopmental disorders.
  • Functional studies in model organisms are crucial for validating the pathogenicity of genetic variants.

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.1K
Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.3K
siRNA - Small Interfering RNAs02:30

siRNA - Small Interfering RNAs

Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
17.1K